Sort
82,697 grants matching “vaccine development”
Translation Research in Plasmodium vivax
$741,583University Of Valle · P50 · FY2002 · AI
Combination Clostridium Difficile Toxin and Adhesin Vaccine
$741,529David D Ho · Aaron Diamond Aids Research Center · R56 · FY2011 · AI
Vaccine Synergy through Synchronous Delivery
$741,448Michael A Barry · Mayo Clinic Rochester · R01 · FY2020 · AI
Natural history, immunity, and transmission patterns of sapovirus in a Nicaraguan birth cohort
$741,394Sylvia Irene Becker-Dreps · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AI
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
$741,356Jun Wang · Rutgers Biomedical And Health Sciences · R01 · FY2022 · AI
Institute of Human Virology Clinical Trials Unit
$741,291Charles Edward Davis · University Of Maryland Baltimore · UM1 · FY2013 · AI
Development of botulinum neurotoxin immunotherapy, serotypes C, D, F, and G
$741,289James D. Marks · University Of California, San Francisco · U01 · FY2010 · AI
Universal T cell targeted influenza vaccine
$741,275Daniel F. Hoft · Saint Louis University · R01 · FY2022 · AI
Vaccines for Extensively Drug Resistant Tuberculosis
$741,248William Robert Jacobs · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · AI
Structural Biology of Influenza Epitopes
$741,246Audray Harris · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Next Generation Development of Broadly Neutralizing HIV Antibodies for Prevention
$741,241Timothy Fouts · Advanced Bioscience Laboratories, Inc. · N01 · FY2021 · AI
Interrogating unique DC adaptations to tissue to promote barrier immunity and tolerance
$741,228Niroshana Anandasabapathy · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AR
Vaccine and Treatment Evaluation Units (VTEU): Concept and Protocol Development
$741,174Daniel Hoft · Saint Louis University · N01 · FY2018 · AI
Engineering CAR-B cells for an HIV-1 functional cure
$741,117Michael R. Farzan · Boston Children'S Hospital · R01 · FY2023 · DA
The yellow fever vaccine saga: Defining the viral and host determinants responsible for success versus failure
$741,079Charles M. Rice · Rockefeller University · R01 · FY2020 · AI
Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core
$741,074Raffit Hassan · Division Of Basic Sciences - Nci · ZID · FY2014 · CA
Sex determination and the sex-determining locus in aedine mosquitoes
$741,056Zhijian Jake Tu · Virginia Polytechnic Inst And St Univ · R01 · FY2025 · AI
Baylor College of Medicine Clinical Trial Unit
$741,043William Thomas Shearer · Baylor College Of Medicine · U01 · FY2009 · AI
Quantitative Detection of Coronary Microvascular Dysfunction in Long COVID Patients using a Comprehensive, Rapid, Free-Breathing Cardiovascular MRI
$741,023Daniel Kim · Northwestern University At Chicago · R01 · FY2024 · HL
Immunological drivers of the transition from epidemicity to endemicity of SARS-CoV-2 in a high transmission LMIC setting
$741,011Albert Icksang Ko · Yale University · R01 · FY2024 · AI
Hydrogel-Based Aged Immune Organoids to Study Epigenetics and Trajectory of B Cells
$741,009Ankur Singh · Georgia Institute Of Technology · R01 · FY2025 · AI
Molecular mapping of microbial communities at the host-pathogen interface by multi-modal 3-dimensional imaging mass spectrometry
$740,949Eric P Skaar · Vanderbilt University Medical Center · R01 · FY2025 · AI
Immunotherapeutics vs Ebola Sudan: Development, Structural & Functional Analysis
$740,922Erica Ollmann Saphire · Scripps Research Institute, The · U01 · FY2010 · AI
Next generation mosquito control through technology-driven trap development and artificial intelligence guided detection of mosquito breeding habitats
$740,913Melissa Suzanne Nolan · University Of South Carolina At Columbia · R01 · FY2023 · AI
A Systems Biology Approach to Malaria Immunity
$740,904Kim C Williamson · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2016 · AI